IDEX Biometrics ASA Listed on Nasdaq

IDEX has listed American Depository Shares (“ADSs”) on Nasdaq, each ADS representing 75 ordinary shares of IDEX. IDEX Biometrics ordinary shares will continue to be admitted to trading on Oslo Børs. The dual listing on Nasdaq and Oslo Børs makes IDEX’s shares more accessible to U.S. institutional and retail investors while also remaining listed on Oslo Børs.

Vince Graziani, CEO at IDEX, says in the stock exchange disclosure: “The listing of our stock on the Nasdaq market represents a significant milestone in our growth as a publicly-traded company, We believe this dual listing will increase our visibility in the U.S. marketplace, while also improving our visibility and liquidity with a broader base of prospective shareholders. This listing also strengthens our position to further enhance market awareness of our innovative biometric products and solutions.”

Ræder’s team, consisting of Carl Garmann Clausen, Kyrre W Kielland and Anja Vestøl Hauge, has together with Cooley LLP acted as legal counsels to IDEX Biometrics throughout the transaction.

US Corporate Desk

Advokatfirmaet Ræder regularly advises national and international clients across industries with transactions - often across national borders. Our lawyers have extensive experience advising listed companies in the technology sector. Several of our lawyers have acquired significant expertise from abroad, two of them duly qualified as New York attorneys, and Ræder is often the preferred advisor on cross border deals.